The global demand for Cardiac Assist Devices Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
A cardiac assist device (CADs) is a mechanical circulatory support device that is an implantable pump that helps pump blood from the heart's lower chambers to the rest of the body. A cardiac assist device is used in people who have weakened hearts or heart failure. They are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD), or to assist both ventricles (BiVAD). They may also be used to provide circulatory support to patients on the waiting list for heart transplantation.
Market Dynamics
Demand for the cardiac assist devices market is projected to grow with rising heart ailments, failure incidence, and heart transplantation. Congestive heart failure (CHF) is a debilitating condition that affects tens of millions of people worldwide and is responsible for more deaths each year than all cancers combined. With the aging population and advances in the treatment of cardiac disease, the number of cardiac assist devices sales continues to increase. Cardiac assist devices are increasingly being used as lifetime support or destination therapy. Improvements in device design and advances in surgical and medical management are anticipated to create new growth opportunities. However, the high cost and risk associated with the treatment and implantation of cardiac assist devices hamper the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac assist devices. The growth and trends of cardiac assist devices industry provide a holistic approach to this study.
Market Segmentation
This section of the cardiac assist devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Ventricular Assist Devices (Vad)
- Intra-Aortic Balloon Pump
- Others
By Modality Type
- Transcutaneous
- Implantable
By End-User
- Hospital
- Ambulatory Surgical Centers
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Cardiac Assist Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Cardiac Assist Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cardiac assist devices market include Abbott Laboratories, Berlin Heart GmbH, Maquet GmbH (Getinge AB), ReliantHeart, Inc., SynCardia Systems, LLC, ABIOMED, Inc., BiVACOR, Inc., Medtronic plc., XENIOS AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.